NOVO-B.CO
NOVO-B.CO
DK0062498333
Novo Nordisk B A/S
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.13T EUR
1.39T EUR
1.02T EUR
1.45T EUR
Enterprise Value
1.23T EUR
1.49T EUR
1.15T EUR
1.55T EUR
Valuation Multiples
Trailing P/E
9.74x
11.95x
8.4x
19.69x
Forward P/E
11.68x
--
--
--
Price to Sales
3.42x
4.23x
3.13x
6.26x
Price to Book
5.11x
6.29x
5.05x
7.45x
EV/Revenue
3.72x
4.52x
3.51x
6.71x
EV/EBITDA
7.06x
9.25x
6.53x
14.51x
Price to FCF (P/FCF)
29.91x
29.13x
33.17x
76.69x
EV/FCF
32.53x
31.13x
37.23x
82.24x
FCF Yield
3.34%
3.43%
3.01%
1.3%
ende